7OE9

C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH rac-N5-((1R,5S)-3-oxabicyclo[3.1.0]hexan-6-yl)-N7,3-dimethyl-3-phenyl-2,3-dihydrobenzofuran-5,7-dicarboxamide

7OE9 の概要

• エントリーDOI: 10.2210/pdb7oe9/pdb
• 関連するPDBエントリー: 7OE8
• 分子名称: Bromodomain-containing protein 2, (3S)-N7,3-dimethyl-N5-[(1R,5S)-3-oxabicyclo[3.1.0]hexan-6-yl]-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide, 1,2-ETHANEDIOL, ... (4 entities in total)
• 機能のキーワード: inhibitor, bromodomain, nuclear protein
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 13949.05

構造登録者

Chung, C. (登録日: 2021-05-02, 公開日: 2021-07-28, 最終更新日: 2024-05-01)

• 主引用文献: Lucas, S.C.C.,Atkinson, S.J.,Chung, C.W.,Davis, R.,Gordon, L.,Grandi, P.,Gray, J.J.R.,Grimes, T.,Phillipou, A.,Preston, A.G.,Prinjha, R.K.,Rioja, I.,Taylor, S.,Tomkinson, N.C.O.,Wall, I.,Watson, R.J.,Woolven, J.,Demont, E.H.; Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors.; J.Med.Chem., 64:10711-10741, 2021; PubMed: 34260229; DOI: 10.1021/acs.jmedchem.1c00344

実験手法

X-RAY DIFFRACTION (1.602 Å)